×
About 1,523 results

ALLMedicine™ Hypersensitivity Pneumonitis Center

Research & Reviews  526 results

Hypersensitivity Pneumonitis: Correct Identification of Causative Microbial Agents Is E...
https://doi.org/10.1164/rccm.202211-2182LE
American Journal of Respiratory and Critical Care Medicine; Dutkiewicz J, Mackiewicz B

Jan 25th, 2023 - Hypersensitivity Pneumonitis: Correct Identification of Causative Microbial Agents Is Essential for Efficient Diagnosis and Prevention.|2023|Dutkiewicz J,Mackiewicz B,|

Reply to: Hypersensitivity Pneumonitis: Correct Identification of Causative Microbial A...
https://doi.org/10.1164/rccm.202301-0025LE
American Journal of Respiratory and Critical Care Medicine; Raghu G, Koziar Vasakova M et. al.

Jan 25th, 2023 - Reply to: Hypersensitivity Pneumonitis: Correct Identification of Causative Microbial Agents Is Essential for Efficient Diagnosis and Prevention.|2023|Raghu G,Koziar Vasakova M,Wilson KC,|

Transbronchial Biopsy
https://emedicine.medscape.com/article/1894323-overview

Jan 23rd, 2023 - Background Transbronchial biopsy is performed by pulmonologists to diagnose focal and diffuse lung diseases. Compared with open lung biopsy, transbronchial biopsy has lower morbidity and mortality. Biopsy of the lung was performed by means of open...

Transbronchial Biopsy Periprocedural Care
https://emedicine.medscape.com/article/1894323-periprocedure

Jan 23rd, 2023 - Preprocedural Planning Occasionally, the patient is premedicated with atropine, glycopyrrolate, or scopolamine in an effort to reduce secretions. These medications are almost outdated. Computed tomography (CT) of the chest is usually performed bef...

Transbronchial Biopsy
http://emedicine.medscape.com/article/1894323-overview

Jan 23rd, 2023 - Background Transbronchial biopsy is performed by pulmonologists to diagnose focal and diffuse lung diseases. Compared with open lung biopsy, transbronchial biopsy has lower morbidity and mortality. Biopsy of the lung was performed by means of open...

see more →

Guidelines  3 results

Executive Summary: Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guid...
https://doi.org/10.1016/j.chest.2021.03.067
Chest Fernández Pérez ER, Travis WD et. al.

Apr 19th, 2021 - The purpose of this summary is to provide a synopsis of evidence-based and consensus-derived guidance for clinicians to improve individual diagnostic decision-making for hypersensitivity pneumonitis (HP) and decrease diagnostic practice variabilit...

Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guideline and Expert Pa...
https://doi.org/10.1016/j.chest.2021.03.066
Chest Fernández Pérez ER, Travis WD et. al.

Apr 17th, 2021 - The purpose of this analysis is to provide evidence-based and consensus-derived guidance for clinicians to improve individual diagnostic decision-making for hypersensitivity pneumonitis (HP) and decrease diagnostic practice variability. Approved p...

Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397797
American Journal of Respiratory and Critical Care Medicine; Raghu G, Remy-Jardin M et. al.

Jul 25th, 2020 - Background: This guideline addresses the diagnosis of hypersensitivity pneumonitis (HP). It represents a collaborative effort among the American Thoracic Society, Japanese Respiratory Society, and Asociación Latinoamericana del Tórax.Methods: Syst...

see more →

Drugs  17 results see all →

Clinicaltrials.gov  26 results

Fibrosing ILD Biomarkers That Rule Acceleration
https://clinicaltrials.gov/ct2/show/NCT05635032

Jan 13th, 2023 - FIBRALUNG is a prospective cohort study with biobank of samples from patients with pulmonary fibrosis, aiming to explore the molecular determinants of different clinical outcomes, acute exacerbations and mortality. We expect to gain deeper insight...

A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis
https://clinicaltrials.gov/ct2/show/NCT04844359

Jan 11th, 2023 - Hypersensitivity pneumonitis is an immunologically mediated form of lung disease, resulting from inhalation exposure to a large variety of antigens. For unknown reasons, a subgroup of patients with HP without a known inciting antigen exposure deve...

Study of Efficacy and Safety of Pirfenidone in Patients With Fibrotic Hypersensitivity Pneumonitis
https://clinicaltrials.gov/ct2/show/NCT02958917

Jan 9th, 2023 - The purpose of this study is to evaluate the potential benefits and the safety of treatment with pirfenidone compared to placebo in subjects with FHP. STUDY SUMMARY This study will include about 42 subjects at National Jewish Health. This is a "do...

An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis
https://clinicaltrials.gov/ct2/show/NCT05626387

Nov 30th, 2022 - Hypersensitivity pneumonitis (HP) is a complex immunologically-mediated interstitial lung disease (ILD) resulting from sensitization to an inhaled antigen. It may be categorized into acute (acute/subacute) or chronic forms based on the duration of...

Database and Biobank of Patients With Hypersensitivity Pneumonitis
https://clinicaltrials.gov/ct2/show/NCT05549635

Nov 4th, 2022 - Sub-study of the main Pulmonary Fibrosis Biomarker (PFBIO) cohort (NCT02755441), recruiting patients with an MDT-diagnosis of hypersensitivity pneumonitis (HP). Patients are included for the collection of blood samples and regular clinical data. T...

see more →

News  36 results

Cough-Specific QOL Linked to Poor Outcomes in ILD Patients
https://www.medscape.com/viewarticle/972378

Apr 19th, 2022 - Poor cough-specific quality of life (QOL) was independently associated with respiratory hospitalization, death, and lung transplantation in a large population of well-characterized patients with interstitial lung disease (ILD), new research shows....

Fast Five Quiz: Progressive Fibrosing Interstitial Lung Disease
https://www.medscape.com/viewarticle/969959

Apr 12th, 2022 - Interstitial lung diseases (ILDs) encompass a large and varied group of parenchymal lung disorders, including diseases of unknown cause, which are known as idiopathic interstitial pneumonias, as well as those associated with other diseases or envi...

Identifying ILD: Symptomology and Work-Up
https://www.onclive.com/view/identifying-ild-symptomology-and-work-up

Sep 15th, 2021 - Transcript: Joyce A. O’Shaughnessy, MD: Charles, how do you define interstitial lung disease [ILD]? Charles A. Powell, MD, MBA: The lung is a window to the world. The lung is exposed to the air that we breathe, and the lung is also fed by our ...

Update – CHEST clinical practice guidelines
https://www.mdedge.com/chestphysician/article/244646/society-news/update-chest-clinical-practice-guidelines
Jonathan M. Iaccarino, MD, MS

Sep 13th, 2021 - CHEST has a long history of developing high quality clinical practice guidelines based on rigorous methodology, particularly in Thoracic Oncology, Pulmonary Vascular/Venous Thromboembolic Disease, and Clinical Pulmonary Medicine/Cough. Using the G.

Bronchiolitis: Rare diseases, diagnostic challenges, and few proven therapies
https://www.mdedge.com/chestphysician/article/234987/pulmonology/bronchiolitis-rare-diseases-diagnostic-challenges-and-few
Brian R. Poole, MD, Sean J. Callahan, MD

Feb 11th, 2021 - What’s in a name? Bronchiolitis, a group of diseases also referred to as “small airways diseases,” is characterized by inflammation and/or fibrosis in airways less than 2 mm in diameter. In pediatric patients, it is most commonly related to acute.

see more →

Patient Education  1 results see all →